EnzymeBioSystems Financial Statements From 2010 to 2025

EnzymeBioSystems' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing EnzymeBioSystems' valuation are provided below:
EnzymeBioSystems does not presently have any fundamental signals for analysis.
Check EnzymeBioSystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnzymeBioSystems' main balance sheet or income statement drivers, such as , as well as many indicators such as . EnzymeBioSystems financial statements analysis is a perfect complement when working with EnzymeBioSystems Valuation or Volatility modules.
  
This module can also supplement various EnzymeBioSystems Technical models . Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

EnzymeBioSystems Company Shares Outstanding Analysis

EnzymeBioSystems' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current EnzymeBioSystems Shares Outstanding

    
  5.59 M  
Most of EnzymeBioSystems' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EnzymeBioSystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition
Based on the latest financial disclosure, EnzymeBioSystems has 5.59 M of shares currently outstending. This is much higher than that of the sector and significantly higher than that of the Shares Outstanding industry. The shares outstanding for all United States stocks is notably lower than that of the firm.

EnzymeBioSystems Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining EnzymeBioSystems's current stock value. Our valuation model uses many indicators to compare EnzymeBioSystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EnzymeBioSystems competition to find correlations between indicators driving EnzymeBioSystems's intrinsic value. More Info.
EnzymeBioSystems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value EnzymeBioSystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for EnzymeBioSystems' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in EnzymeBioSystems Pink Sheet

If you are still planning to invest in EnzymeBioSystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EnzymeBioSystems' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments